A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

'We sold the family home': Organic farm liquidated
Primary Sector

'We sold the family home': Organic farm liquidated

The Ōamaru farm was set to be the subject of a Country Calendar episode.

Gregor Thompson 05 Jun 2025
Meet the new boss of Fonterra's foodservice business
Primary Sector

Meet the new boss of Fonterra's foodservice business

Teh-han Chow led Fonterra's Greater China business for six years.

Riley Kennedy 03 Jun 2025